Koch Industries and CK Hutchison both participated in a series D round that pushed the medical imaging system developer's total funding to more than $124m.

Israel-based blood analysis device developer Sight Diagnostics secured $71m in series D financing on Wednesday from investors including chemical manufacturer Koch Industries and diversified conglomerate CK Hutchison.

Equity crowdfunding platform OurCrowd also took part in the round. Koch Industries and CK Hutchison participated through Koch Disruptive Technologies and Longliv Ventures respectively.

Sight Diagnostics has developed imaging technology dubbed Sight OLO that can capture more than 1,000 images of a blood sample as small as two drops, and which uses artificial…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Email LinkedIn